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To develop and characterize a novel cell culture method for the generation of undifferentiated and differentiated
human mesenchymal stem cell 3D structures, we utilized the RWV system with a gelatin-based scaffold. 3 × 106
cells generated homogeneous spheroids and maximum spheroid loading was accomplished after 3 days of culture.
Spheroids cultured in undifferentiated spheroids of 3 and 10 days retained expression of CD44, without expression
of differentiation markers. Spheroids cultured in adipogenic and osteogenic differentiation media exhibited oil red
O staining and von Kossa staining, respectively. Further characterization of osteogenic lineage, showed that 10 day
spheroids exhibited stronger calcification than any other experimental group corresponding with significant
expression of vitamin D receptor, alkaline phosphatase, and ERp60 . In conclusion this study describes a novel RWV
culture method that allowed efficacious engineering of undifferentiated human mesenchymal stem cell spheroids
and rapid osteogenic differentiation. The use of gelatin scaffolds holds promise to design implantable stem cell
tissue of various sizes and shapes for future regenerative treatment.
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Stem cell-based therapies offer tremendous advantages
for the treatment of orthopedic defects. One of the most
widely studied stem cells are human mesenchymal stem
cells (hMSC). HMSCs display a very high degree of plas-
ticity and are found in virtually all organs, however, the
bone marrow contains the highest density [1]. HMSCs
serve as renewable source for mesenchymal [2] and
potentially epithelial cells and have pluripotent ability of
differentiating into several cell lineages, including osteo-
blasts, chondrocytes, adipocytes, skeletal and cardiac
myocytes, endothelial cells, and neurons in vitro upon
appropriate stimulation, and in vivo after transplantation
[3]. Although the pathophysiologic functions of hMSCs
are critically under investigation, the in vitro pluripo-
tency of hMSC suggests a role in tissue regeneration,
wound healing, or tissue repair after transplantation [4].
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reproduction in any medium, provided the orautologous transplantation with the genuine benefits for
tissue regeneration or cell-based gene therapies [5].
HMSCs isolated from the bone marrow have several
limitations, however, the most paramount is the limited
number of cells easily obtainable. Limited cell number
presents further constraints, particularly for autologous
transplantation, as the number of cells per area on tissue
culture plates requires multiple passaging and potential
loss of pluripotency [6]. An additional hurdle is the
length of time required to promote lineage-specific
differentiation. For example, it is well established that 3
to 4 weeks of in vitro incubation of hMSC monolayers
with osteogenic differentiation media is required for
calcium accumulation and positive von Kossa staining
[7]. Various matrices or scaffolds have been employed to
promote differentiation such as porous gelatin, poly-
ethylene terephthalate, or thermo-reversible gelatin poly-
mer [8-10]. The scaffold is a very important component
for promoting tissue differentiation because it represents
a structure, which the cells attach to and colonize in
order to produce three-dimensional (3D) tissues. One
such scaffold is gelatin sponge. Gelatin sponge is a por-
ous denatured gelatin scaffold and has been previouslyal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and adipogenic differentiation under appropriate condi-
tions [11]. In addition gelatin sponge is an ideal scaffold
as its porous gelatin properties favor cell adhesion pro-
teins, which is the first basic step toward cell growth
[12]. Furthermore, the use of gelatin-based scaffolds
avoids the need for chemical surfactants that could be
detrimental to the biocompatibility in certain systems.
To circumvent the challenges of in vitro and in vivo
expansion of hMSCs, several ex vivo systems have been
proposed. Ex vivo approach has several advantages, par-
ticularly for tissue-specific repair, delivery of targeted
anticancer agents, or for allogenic transplantation [4].
While all these methods were able to induce hMSC dif-
ferentiation, efficacy (i.e. cell load) has been poor and
the time to differentiation has still remained at the 3 to
4 week period. The system we used in this study, the Ro-
tary Wall Vessel (RWV) system, has been previously
used to simulate the effects of a microgravity or RWV
environment on numerous cell culture systems [13,14].
Herein we present the use of RWV microgravity (MG)
system as a novel culture methodology that facilitates
the generation of multicellular undifferentiated mesen-
chymal stem cell spheroids that retain differentiation po-
tential into multiple independent cell lineages. Our work
has established defined ex vivo culture conditions for
enhanced hMSC multicelluar aggregation and acceler-
ated differentiation with the potential to deliver either
undifferentiated or pre-differentiated cells to the site of
injury to aid repair. Therefore, culture conditions that
reduce hMSC differentiation predictably would provide
standardization that is critical to establish a broad clin-
ical adoption and potential allogenic transplantation.
Materials and methods
Cell culture
Human mesenchymal stem cells were purchased from
Lonza (Walkersville, MD, #PT-2501). As specified by the
company, hMSC are harvested and cultured from nor-
mal human bone marrow. Cells are tested for purity by
flow cytometry and for their ability to differentiate into
osteogenic, chondrogenic, and adipogenic lineages. Cells
are positive for CD29, CD44, CD105, CD133 and
CD166. Cells are negative for CD14, CD34, and CD45.
HMSCs were cultured in mesenchymal stem cell media
(Lonza, Walkersville, MD, #PT-3001) and cell propaga-
tion was limited to passage 7.
Three-dimensional cell culture
1 × 1 × 1 mm porous gelatin (Ferrosan, Soeborg, DK,
#H206197412), was soaked in undifferentiated stem cell
media until all air was expelled; it remained positively
buoyant. 10 ml of cell suspension including porous
gelatin (scaffold) were transferred to a RWV vessel andair was removed. The RWV system was set at a rota-
tional speed of 4 rounds per minute (rpm) and cells
were cultured at 37°C and 5% CO2. A spheroid adhering
to the scaffold was generated, and media was exchanged
every 3 to 4 days. Differentiation was induced utilizing
chondrogenic, osteogenic, and adipogenic differentiation
media, obtained from Lonza (#PT-3003, #PT-3002, #PT-
3004), after 3 days of RWV culture. Spheroids in undif-
ferentiated control growth media or differentiation
media were cultured for additional 7 days.
DNA quantification
The number of hMSCs attached to the porous gelatin
core was determined by quantification of DNA content
per spheroid. DNA quantification was performed using
the DNeasy tissue kit (Qiagen, Valencia, CA, #69504)
and cell number extrapolated from an hMSC standard
curve.
Histology
All specimens were fixed in 10% formalin, embedded in
paraffin, and stained for H&E. In addition, frozen sec-
tions were assessed for adipogenic differentiation with
oil red O stain and for osteogenic differentiation with
von Kossa stain. Chondrogenic differentiation was evalu-
ated by immunohistochemistry (IHC) using antibodies
against collagen type II (Santa Cruz, CA, sc-52658) at a
dilution of 1: 10, and against aggrecan (Santa Cruz, CA,
sc-73693) at a dilution of 1:100. CD44 (Abcam,
Cambridge, MA, ab24504) at 1:50, CD133 (Abcam,
Cambridge, MA, ab19898) at 1:250, and CD166 (Abcam,
Cambridge, MA, ab53442) at 1:10 antibodies were used
to evaluate stem cell surface markers. Cell proliferation
was assessed by staining Ki-67 (Santa Cruz, CA, sc-7844)
with a 1:100 antibody dilution. Spheroid calcification was
further studied by IHC against alkaline phosphatase (AP)
(Abcam, Cambridge, MA, ab75699) at 1:100, nuclear vita-
min D receptor (Santa Cruz, CA, sc-1008) at 1:500, mem-
brane vitamin D receptor (ERp60) (Alpha Diagnostics
International, San Antonio, TX, Ab100) at 1:1000. Intra-
and intercellular architecture was studied by transmission
electron microscopy (TEM), performed at University of
Alabama, Birmingham.
Results
Gelatin sponge is a scaffold, which has pores separated
by thin (few μm in thickness) walls [15]. We employed a
cell loading procedure utilizing empirically determined
1 × 1 × 1 mm sponge scaffold to maximize hMSC loading
and future engrafting (Figure 1).
As hMSC loading onto gelatin sponges in MG condi-
tions has not previously been characterized, we first
determined efficacy of hMSC loading onto the gelatin
scaffold under MG conditions. 2 × 106 to 4 × 106 hMSC
Figure 1 Schematic of generation of multicellular spheroids. 2D cultured hMSC were suspended in growth media in the presence of scaffold. Cell
suspensions containing scaffolds were transferred to RWV rotary cell culture system and cultured at 4 rounds per minute for designated time intervals.
After designated time intervals multicellular spheroids were sectioned and examined for cellularity and differentiation status.
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gelatin scaffold. 2 × 106 hMSC/10 ml resulted in incom-
plete loading of the scaffold and partial spheroid forma-
tion, as determined by histological examination (data
not shown). However, 3 × 106 cells/10 ml produced a
homogeneous multi-cellular tissue-like spheroid around
the porous gelatin core
We further characterized the length of time required
to maximum spheroid size and cell loading. 3 x106 cells/
10 ml hMSC spheroids were harvested at 1, 2, 3, 4, and
8 days of MG culture. Total DNA of spheroids was
extracted and normalized to 2D cultured cells to
extrapolate the exact number of cells within spheroids.
Our results show that maximum spheroid loading was
achievable by 3 days with a mean of 3.67 × 106cells per
spheroid, representing 12% efficacy in cell loading
(Figure 2A). Spheroid loading progressively declined
after day 3, as determined by number of remaining cells
in suspension; however spheroid size was maintained
throughout (Figure 2B). Upon subsequent removal of
hMSC coated gelatin scaffolds, we noticed that the rigid
structure was maintained, suggesting an implantable
construct (Figure 1). Hematoxylin and eosin (H&E)
staining of sectioned spheroids confirmed these finding
and highlighted a concentric rim of cells in the periphery
with cell-cell connections and multi-cellular aggregation,
with cells sparsely adherent near the porous space
adjacent to the center of the spheroid (Figure 2C).
Throughout the spheroid hMSC appear to maintain
their mesenchymal phenotype and form cell-cell connec-
tions, which is further evident at increased magnification
by TEM (Figure 2D). Since we determined the most sig-
nificant cellularity and adherence to the gelatin scaffold
at 3 days, we continued further characterization from
this time point on.
Numerous reports have provided compelling evidence
that hMSC enhance organ repair. However, a major obs-
tacle is the delivery of a sufficient number of undifferen-
tiated cells to the site of injury. Therefore, it is essentialthat MG conditions do not alter hMSC multi-lineage
differentiation potential. To determine whether 3 day
spheroids, cultured under maintenance conditions alone,
retained stem cell markers, we evaluated expression of
stem cell markers (CD44, CD133, CD166) and common
markers for osteogenic, adipogenic, and chondrogenic
differentiation by staining for von Kossa, oil red O, col-
lagen II, and aggrecan, respectively over an additional
10 day period. Spheroids harvested after three days
showed robust expression of CD44, CD133, and CD166
(Figure 3A), which is similar to hMSC cells cultured on
2D surfaces [16]; however, spheroids harvested after
10 days demonstrated a loss of CD133 and CD166 ex-
pression. Additionally, 10 day spheroids did not exhibit
von Kossa staining or collagen II/aggrecan expression,
however, we did observe low levels of oil red O staining
(Figure 3B).
Since 3 day spheroids appeared to retain stem cell
markers, we sought to determine if lineage-specific
differentiation could be induced subsequent to 3 days of
culture under MG conditions. Therefore, 3 day spheroids,
previously cultured under maintenance conditions, were
cultured in pre-defined media for chondrogenic, osteo-
genic and adipogenic differentiation for an additional
7 days, and compared to cells that remained in growth
media only.
Spheroids cultured in chondrogenic media demon-
strated histological changes on H&E stain (data not
shown) such as clear cell appearance and cell aggregates
indicating imminent differentiation. While CD133 and
CD166 expression was undetectable, CD44 expression
was detected throughout (Figure 4A). Expression of
chondrogenic marker collagen type II and aggrecan was
also absent after 3 and 10 days of culture in both control
and chondrogenic media (Additional file 1: Figure S1),
however, there were significant levels of adipogenic mar-
ker oil red O staining (Figure 4A).
In spheroids cultured under adipogenic conditions, we
observed a similar pattern with decreased expression of
Figure 2 Quantification of hMSC loading onto gelatin scaffolds under MG conditions. (A) Number of cells loaded onto spheroids was
determined by quantification of DNA content per spheroid over an 8 day period. (B) Number of cells that remained in suspension over an 8 day
period. All data presented are the mean of three independent experiments ± SE. (C) H&E staining of day 3 spheroid at 10x and 40x magnification
shows multi-cellularity and absence of necrosis. (D) TEM images of day 3 spheroid show cell structure was maintained in MG. Images shown are
representative of 4 individual experiments.
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(Figure 4A). As expected we observed significant
increases in oil red O staining, demonstrating increased
amounts of lipids in all specimens of all experimental
groups. We did not observe positive von Kossa or colla-
gen II staining, suggesting a commitment to adipogenic
lineage (Figure 4B).
Lastly, we determined whether osteogenic differenti-
ation conditions would override the seemly adipogenic
default lineage observed with 3 day and 10 day cultures.
10 day spheroids in osteogenic differentiation conditions
resulted in significant von Kossa staining, suggesting
mineralization and calcification in 10 day spheroids
(Figure 4C). As with the chondrogenic and adipogenic
spheroids, we did not observe expression of CD133 or
CD166, however, CD44 expression remained (Figure 4C).
We did observe low level of oil red staining O but collagen
II and aggrecan staining was completely absent.
Since mineralization appeared to occur on day 10, we
further sought to determine if this mineralization wasassociated with additional markers of osteogenesis, alka-
line phosphatase (ALP), nuclear vitamin D receptor
(VDR) and membrane vitamin D receptor (ERp60) over
the 10 day culture period. ALP staining was completely
absent in 3 day spheroids, however, we did detect ex-
pression at 10 days under control and osteogenic condi-
tions (Figure 5A). We also observed significant levels of
nuclear VDR and ERp60 expression in the 3 day and
10 day control and osteogenic spheroids (Figure 5A).
Robust Ki-67 expression was observed in undifferenti-
ated and differentiated cultured conditions. (Figure 5B).
Thus, it appears that these studies provide proof-of-
principle that hMSC can be induced toward the osteo-
genic lineage under MG conditions.
Discussion
Conventional reconstructive surgery has employed au-
tologous, biological, and artificial materials in an effort
to reestablish normal human anatomy and function,
however, often trigger immunological or organ-specific
Figure 4 Induced differentiation of hMSC spheroids cultured under MG conditions. (A) Immunohistochemistry analysis of hMSC cultured
for 10 days in A, chrondrogenic media shows negative staining for collagen. (B) hMSC spheroids cultured under adipogenic conditions show
positive oil read O staining. (C) hMSC spheroids cultured under osteogenic conditions were positive with von Kossa staining. Images shown are
representative of 4 individual experiments.
Figure 3 Differentiation of hMSC spheroids cultured under MG conditions. (A) Immunohistochemistry analysis of spheroids for stem cells
makers CD44, CD133, CD166, and differentiation markers von Kossa, oil red O, collagen-II showed that day 3 spheroids retained CD44, CD133, and
CD166 expression and lacked differentiation markers. (B) Day 10 spheroids retain CD44 expression and were positive for oil red O staining. Images
shown are representative of 4 individual experiments.
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Figure 5 Osteogenic differentiation of hMSC spheroids cultured under MG conditions. (A) Immunohistochemical analysis of alkaline
phosphatase (AP), vitamin D receptor (VDR), and ERp60 expression in hMSC spheroids after day 3 and day 10 with and without osteogenic conditions.
(B) Immunohistochemical analysis of proliferation marker Ki-67 at day 3 and day 10. Images shown are representative of 4 individual experiments.
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inherent problems of introduced materials by generating
tissue that conforms to site-specific anatomy and func-
tion. To facilitate tissue regeneration, several studies
have been performed using various biomaterials inassociation with different cell types (i.e. osteoblasts,
osteoclasts and endothelial cells) under 2D and 3D con-
ditions for bone repair, however, there have been few
reports investigating the osteogenic differentiation of
hMSC under MG conditions.
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simulate microgravity conditions, however, we and others
have utilized this system for the RWV culture of cells
[17,18]. This system encompasses the features of low-shear
stress, high mass transfer environment, comparable to the
weightless state that is characteristic of blood, lymphatic
fluid, or even in the bone marrow [19,20]. Additionally, this
system has been extremely useful in determining cellular
interactions between cancer and host bone marrow stro-
mal cells [21], and in studying therapeutic options for
many pathological situations, which include radiation re-
sistance, phenotypic differentiation, and response to tar-
geted drug delivery. In this study we utilized the RWV
system, which models microgravity (MG) conditions, with
a gelatin sponge scaffold, to explore the possibility that
hMSC, with an appropriate scaffold, will facilitate cell
growth and organization, as well as directed differentiation,
and that it can be utilized for regeneration of bone cells.
Previous studies have shown that gelatin scaffold sup-
ports the differentiation of hMSC or other stem cells
into multiple lineages including osteogenic, chondro-
genic, and adipogenic on 2D surfaces [11,22,23]. How-
ever, differentiation of hMSC cultured under modeled
microgravity has not been determined. Our initial results
indicate that hMSC cultured in the RWV system with
gelatin scaffold support randomized adherence to the
gelatin scaffold with near complete cell uptake within
the gelatin-based spheroid as measured by DNA content
after 3 days of culture. These findings are supported by
previous reports that numerous scaffolds including
microcarrier beads or collagen-coated sponges support
cell attachment in vitro [24]. Although collagen is a
major component of the bone matrix, we did not ob-
serve significant cell attachment with collagen-coated
scaffolds (data not shown). Thus, we utilized uncoated
gelatin sponges for the remainder of our studies.
Upon histological examination, 3 day control spheroids
showed increased cell organization with a homogeneous
multi-cellular tissue-like structure that completely coated
the 1x1x1 mm scaffold. A high proliferative index, deter-
mined by Ki-67 staining, was seen as well. Interestingly,
we did not observe any necrosis, which is typical of RWV
engineered tissue-like structures greater than 200 μm in
size in bioreactor systems [25,26]. Thus, it is possible that
the gelatin sponge facilitates diffusion of nutrients and
oxygen, not typically observed with more rigid scaffold
designs. Surprisingly, these findings are in contrast to a
study [27] that reported a decrease in the viability and pro-
liferation of cells cultured in the RWV bioreactor under
modeled MG conditions. Although we did find a decrease
in attachment of free floating cells, viability and prolifera-
tion remained through all experimental time points.
In order to determine the effects of MG on hMSC
differentiation, we further characterized the spheroidsover a 10 day period. Early differentiation (3 days) was
not observed since undifferentiated stem cell markers
CD44, CD133, and CD166 were robustly expressed and
typical markers associated with lineage-specific differen-
tiation (von Kossa, oil red O, collagen II, aggrecan) were
not detected. Indeed, we did detect isolated lipid depos-
its, (oil red O staining) within the spheroids, suggesting
the spheroids were pre-adipogenic. However, given the
relatively low oil red O staining and presence of stem
cells markers, it appears that after 3 days of MG, hMSCs
largely remain undifferentiated.
The pluripotent potential of spheroids was further
demonstrated after 10 day culture under defined differenti-
ation conditions (shown to promote adipogenic, chondro-
genic, and osteogenic differentiation, respectively). As
expected, we observed early lipid deposits (3 days) and
strong lipid deposits in 10 day control and adipogenic cul-
tured cells. These findings are similar to Zayzafoon’s study
[24] that concluded that hMSC, cultured on microcarrier
beads in MG, undergo adipogenic differentiation opposed
to other lineages including cells cultured in divergent
differentiation-inducing conditions. The authors further
concluded that the adipogenic lineage represents the
default pathway of hMSC cultured under MG conditions.
However, our findings do not completely reflect this
hypothesis. hMSC cultured under osteogenic conditions,
after 10 days exhibited robust von Kossa staining, suggest-
ing calcification and mineralization, and VDR staining
which is responsible for mineral stability [28-30]. Addition-
ally, we observed ALP expression, which is produced by
osteoblastic cells and represents a definitive marker for
early osteogenesis [31,32]. Loss of stem cell markers CD133
and CD166 expression in all differentiation conditions fur-
ther support the pluripotency of 3 day spheroids and the
commitment to cellular differentiation after 10 days.
Osteogenic differentiation of mouse bone marrow stro-
mal cells in RWV system has been previously reported
[27]. Conditioned media from mature osteoblasts were
able to induce increased osteoclastogenesis and bone re-
sorption in mouse bone marrow cultures via indirect
stimulation of osteoclast formation and activity by regulat-
ing osteoblast secretion of regulatory factors such as
RANKL and OPG. VDR regulates the expression of bone
matrix proteins and promotes osteoclast differentiation by
inducing the expression of RANKL. We observed an in-
crease in VDR expression and constant expression of
ERp60, a membrane-associated receptor implicated in the
rapid actions of 1,25(OH)2D [33], in 3 day and 10 day
spheroids (control or osteogenic condition), along with
increased ALP expression and mineralization. These find-
ings suggest that exogenous or endogenous soluble ligands
(i.e. RANKL/OPG) are required to override the adipogenic
default lineage and promote osteoblast formation of
hMSC in MG conditions. Our observation of a low level
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conditions, further supports a directive role of gelatin scaf-
fold. Indeed, since the biocompatibility of gelatin likely
facilitates cell attachment, which is required to promote
differentiation and proliferation, it likely plays a role in
promoting osteogenic properties of hMSC under MG
conditions
In conclusion, this study provides greater insight into
the effects of MG on hMSC osteogenic differentiation.
Furthermore, this model establishes a rapid culture
method that overcomes the bone diminishing effects of
MG on hMSC osteogenesis and provides a system to de-
termine the cellular and molecular mechanisms that are
associated with this decline. Although the pluripotency
of MG-cultured hMSC within the gelatin scaffold has
yet to be verified in vivo in regard to bone regeneration,
our system provides undifferentiated, cell-coated, and
implantable constructs for tissue engineering and ex vivo
modeled organogenesis.
Additional file
Additional file 1: hMSC spheroids do not display chrondrogenic
markers cultured under MG conditions. Immunohistochemistry
analysis of day 3 or day 10 period spheroids cultured in control or
chrondrogenic media conditions were negative for chrondrogenic
markers aggrecan or collagen-II. Images shown are representative of 4
individual experiments.
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